Royalty Pharma
Open Search
Open Navigation
Our firm
Back
Our firm
Our story
Our approach
Our portfolio
Our culture
Financial highlights
Leadership team
Board of directors
Working at Royalty Pharma
Learn more about Royalty Pharma
Partners
Back
Partner with us
Back
Partner with us
Biotechnology
Global pharmaceuticals
Academic institutions & non-profits
Our portfolio
Types of partnerships
Back
Types of partnerships
Existing royalties
Synthetic royalties
Launch & development capital
Facilitating M&A
Why partner with Royalty Pharma
Investors
Back
Investors
Why invest in Royalty Pharma
Stock information
Quarterly results
SEC filings
Annual reports
Investor resources
Events
Corporate governance
Portfolio product information
Analyst coverage
Tax information
Contact us
Corporate presentation
Responsibility
Back
Responsibility
Back
Responsibility
Business oversight
Access to healthcare
Building and supporting talent
Responsibility resource center
Supporting our communities
2023 Corporate Responsibility Report
News
Accelerating Bio-Innovation Conference
Search
Search
Close Search Panel
Royalty Pharma Vorasidenib Transaction Call
05/28/24 at 8:30am
Click here for webcast
Vorasidenib Transaction Press Release
Vorasidenib Transaction Presentation
Vorasidenib Transaction Call Transcript
Stay up to date
Subscribe to Royalty Pharma news and alerts
Subscribe
